Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 201-286-1 | CAS number: 80-51-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1999
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: The study was performed in accordance with OECD guideline 401 and GLP standard.
Cross-reference
- Reason / purpose for cross-reference:
- reference to same study
Data source
Reference
- Reference Type:
- publication
- Title:
- Unnamed
- Year:
- 2 006
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Deviations:
- not specified
- Principles of method if other than guideline:
- NA
- GLP compliance:
- yes
- Test type:
- standard acute method
- Limit test:
- no
Test material
- Reference substance name:
- 4,4'-oxydi(benzenesulphonohydrazide)
- EC Number:
- 201-286-1
- EC Name:
- 4,4'-oxydi(benzenesulphonohydrazide)
- Cas Number:
- 80-51-3
- Molecular formula:
- C12H14N4O5S2
- IUPAC Name:
- 4-[4-(hydrazinesulfonyl)phenoxy]benzene-1-sulfonohydrazide
- Test material form:
- solid: particulate/powder
- Remarks:
- migrated information: powder
- Details on test material:
- - Name of test material (as cited in study report): 4,4'-Oxybis (benzenesulfonyl hydrazide)
- Analytical purity: > 99%
- Purity test date: no data
- Lot/batch No.: 990819
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: no data
- Age at study initiation: 5 weeks
- Weight at study initiation: 157-197g for male, 132-151g for female
- Fasting period before study: Rats were fasted for approximately 16 hours prior to dosing the test substance, but drinking water was freely ingested in the cage.
- Housing: no data
- Diet (e.g. ad libitum): no data
- Water (e.g. ad libitum): ad libitum
- Acclimation period: no data
ENVIRONMENTAL CONDITIONS
- Temperature (°C): no data
- Humidity (%): no data
- Air changes (per hr): no data
- Photoperiod (hrs dark / hrs light): no data
IN-LIFE DATES: no data
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- corn oil
- Details on oral exposure:
- VEHICLE
- Concentration in vehicle:
- Amount of vehicle (if gavage):
- Justification for choice of vehicle:
- Lot/batch no. (if required):
- Purity:
MAXIMUM DOSE VOLUME APPLIED:
DOSAGE PREPARATION (if unusual):
CLASS METHOD (if applicable)
- Rationale for the selection of the starting dose: - Doses:
- 0, 1000, 2000 and 3000 mg/kg
- No. of animals per sex per dose:
- 5 males and 5 females per dose group
- Control animals:
- yes
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: The animals were observed for clinical signs of toxicity just before the administration at 1, 2, 3, 4, 5, and 6 hrs after dosing on day 1 and once a day until day 14. Individual body weights of animals were measured just before the administration, on day 3, 7 and the day of necropsy.
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight,necropsy - Statistics:
- The body weight changes were analyzed using the Student’s t-test.
Results and discussion
Effect levels
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- >= 1 000 - <= 2 000 mg/kg bw
- Mortality:
- During the observation period, all males and four females died at both 2,000 and 3,000 mg/kg bw.
- Clinical signs:
- other: In case of dead rats, the paralysis of forelimb and hindlimb, cloudy eyeball, and lacrimation on day 2 after the administration were observed in those groups. The slight paralysis of hindlimb was observed in 2 males and 2 females at 1,000 mg/kg bw and 1 f
- Gross pathology:
- Dead animals of the 2,000 and 3,000 mg/kg groups showed dark-red discoloration of the brain and lung, and the atrophic thymus and spleen. In scheduled necropsy, however, no macroscopic abnormalities were seen in the surviving animals.
- Other findings:
- None
Any other information on results incl. tables
Table1. Mortality and clinical signsof the acute oral toxicity
Sex |
Group |
No. of animals |
Findings |
Days after treatment |
|||||||||||||
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
9 |
10 |
11 |
12 |
13 |
14 |
||||
Male |
C |
5 |
N |
5 |
5 |
5 |
5 |
5 |
5 |
5 |
5 |
5 |
5 |
5 |
5 |
5 |
5 |
T1 |
5 |
N |
5 |
5 |
5 |
4 |
3 |
4 |
4 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
|
P* |
|
|
|
1 |
2 |
1 |
1 |
2 |
2 |
2 |
2 |
2 |
2 |
2 |
|||
T2 |
5 |
N |
5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
P |
|
5 |
5 |
5 |
5 |
|
|
|
|
|
|
|
|
|
|||
C |
|
5 |
4 |
5 |
5 |
|
|
|
|
|
|
|
|
|
|||
L |
|
|
|
5 |
5 |
|
|
|
|
|
|
|
|
|
|||
D |
|
|
|
|
|
5 |
|
|
|
|
|
|
|
|
|||
T3 |
5 |
N |
5 |
|
1 |
1 |
1 |
|
|
|
|
|
|
|
|
|
|
P |
|
5 |
4 |
1 |
1 |
1 |
|
|
|
|
|
|
|
|
|||
C |
|
|
2 |
1 |
1 |
1 |
1 |
|
|
|
|
|
|
|
|||
H |
|
|
|
|
|
1 |
1 |
|
|
|
|
|
|
|
|||
L |
|
|
1 |
1 |
1 |
1 |
|
|
|
|
|
|
|
|
|||
D |
|
|
|
3 |
|
1 |
|
1 |
|
|
|
|
|
|
|||
Female |
C |
5 |
N |
5 |
5 |
5 |
5 |
5 |
5 |
5 |
5 |
5 |
5 |
5 |
5 |
5 |
5 |
T1 |
5 |
N |
5 |
4 |
4 |
3 |
3 |
3 |
3 |
4 |
5 |
5 |
5 |
5 |
5 |
5 |
|
P* |
|
1 |
1 |
2 |
2 |
2 |
2 |
1 |
|
|
|
|
|
|
|||
T2 |
5 |
N |
5 |
|
|
|
|
|
|
|
|
|
|
|
|
1 |
|
P |
|
5 |
4 |
2 |
1 |
|
|
|
|
|
|
|
|
|
|||
C |
|
|
1 |
|
|
|
|
|
|
|
|
|
|
|
|||
P* |
|
|
|
1 |
2 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
|
|||
D |
|
|
1 |
1 |
|
2 |
|
|
|
|
|
|
|
|
|||
T3 |
5 |
N |
5 |
2 |
2 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
|
P |
|
3 |
3 |
4 |
3 |
1 |
|
|
|
|
|
|
|
|
|||
D |
|
|
|
|
1 |
2 |
1 |
|
|
|
|
|
|
|
Table 2. Body weights of male and female rats
Group |
|
Mean body weight (g) of males |
Mean body weight (g) of females |
||||||
Day 0 |
Day 3 |
Day 7 |
Day 14 |
Day 0 |
Day 3 |
Day 7 |
Day 14 |
||
C |
Mean |
153.3 |
194.7 |
232.1 |
296.6 |
125.1 |
153.2 |
172.8 |
195.7 |
|
S.D. |
11.1 |
12.0 |
15.1 |
20.7 |
4.2 |
6.9 |
8.6 |
13.3 |
|
N |
5 |
5 |
5 |
5 |
5 |
5 |
5 |
5 |
T1 |
Mean |
160.9 |
172.2 |
201.8 |
274.6 |
127.7 |
142.0 |
165.1 |
196.5 |
|
S.D. |
7.1 |
23.9 |
41.8 |
39.2 |
5.0 |
10.4 |
7.1 |
9.8 |
|
N |
5 |
5 |
5 |
5 |
5 |
5 |
5 |
5 |
T2 |
Mean |
163.7 |
141.1** |
0.0 |
0.0 |
123.2 |
109.6** |
120.4 |
162.4 |
|
S.D. |
8.0 |
10.9 |
0.0 |
0.0 |
5.7 |
3.8 |
0.0 |
0.0 |
|
N |
5 |
5 |
0 |
0 |
5 |
5 |
1 |
1 |
T3 |
Mean |
160.2 |
134.4** |
108.6 |
0.0 |
128.0 |
123.8* |
186.0 |
215.0 |
|
S.D. |
9.3 |
7.1 |
0.0 |
0.0 |
5.9 |
19.4 |
0.0 |
0.0 |
|
N |
5 |
5 |
1 |
0 |
5 |
5 |
1 |
1 |
Applicant's summary and conclusion
- Conclusions:
- The acute oral toxicity of OBSH was assessed in rats following a single administration of OBSH. The study was performed in compliance with OECD guideline 401. The acute oral median lethal dose (LD50) of OBSH was estimated to be between 1000 and 2000 mg/kg bw under the test conditions.
According to CLP criteria OBSH should be classified as Acute tox 4; H302. - Executive summary:
This study was conducted to assess the acute toxicity of OBSH following a single oral administration of 0, 1000, 2000 and 3000 mg/kg bw. This study is performed in accordance with the testing guideline OECD (401).
Groups of five males and five female fasted rats were given OBSH as a single dose on Day 1 by oral gavage at a dose level of 0, 1000, 2000 and 3000 mg/kg. OBSH was administrated in corn oil.
Following a single administration of OBSH to rats, the acute median lethal oral dose for male and female rats was estimated to be between 1000 and 2000 mg/kg bw under the test conditions.
According to CLP criteria OBSH should be classified as Acute tox 4; H302.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.